These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 3488004)
1. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Hance AJ; Basset F; Saumon G; Danel C; Valeyre D; Battesti JP; Chrétien J; Georges R Ann N Y Acad Sci; 1986; 465():643-56. PubMed ID: 3488004 [TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Daniele RP; Elias JA; Epstein PE; Rossman MD Ann Intern Med; 1985 Jan; 102(1):93-108. PubMed ID: 3881071 [TBL] [Abstract][Full Text] [Related]
4. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Valeyre D; Soler P; Clerici C; Pré J; Battesti JP; Georges R; Hance AJ Thorax; 1988 Jul; 43(7):516-24. PubMed ID: 2850637 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Chollet S; Soler P; Dournovo P; Richard MS; Ferrans VJ; Basset F Am J Pathol; 1984 May; 115(2):225-32. PubMed ID: 6372496 [TBL] [Abstract][Full Text] [Related]
6. Morphologic changes of alveolar macrophages in smoking sarcoidosis patients. Leuenberger P; Vonmoos S; Vejdovsky R Eur J Respir Dis Suppl; 1985; 139():72-5. PubMed ID: 2412876 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Hunninghake GW; Kawanami O; Ferrans VJ; Young RC; Roberts WC; Crystal RG Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):407-12. PubMed ID: 7224352 [No Abstract] [Full Text] [Related]
10. Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Semenzato G; Chilosi M; Ossi E; Trentin L; Pizzolo G; Cipriani A; Agostini C; Zambello R; Marcer G; Gasparotto G Am Rev Respir Dis; 1985 Aug; 132(2):400-4. PubMed ID: 3896081 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme in serum and in bronchoalveolar lavage in sarcoidosis. Gupta RG; Sicilian L; Catchatourian R; Bekerman C; Oparil S; Szidon JP Respiration; 1982; 43(3):153-7. PubMed ID: 6287548 [TBL] [Abstract][Full Text] [Related]
12. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. Crystal RG; Bitterman PB; Rennard SI; Hance AJ; Keogh BA N Engl J Med; 1984 Jan; 310(4):235-44. PubMed ID: 6361563 [No Abstract] [Full Text] [Related]
13. Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis. du Bois RM; Townsend PJ; Cole PJ; Haslam PL; Turner-Warwick M Clin Allergy; 1981 Sep; 11(5):409-19. PubMed ID: 7318160 [TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Haslam PL; Turton CW; Lukoszek A; Salsbury AJ; Dewar A; Collins JV; Turner-Warwick M Thorax; 1980 May; 35(5):328-39. PubMed ID: 7434282 [TBL] [Abstract][Full Text] [Related]
15. [Apoptosis of alveolar lymphocytes in sarcoidosis and in control group is more frequent in smokers than in nonsmoking persons]. Kopiński P; Przybylsk G; Balicka-Slusarczyk B; Jarzemska A; Dyczek A; Pinis G; Bartczak K; Plato M; Jankowski M; Szczeklik J Przegl Lek; 2006; 63(10):841-7. PubMed ID: 17288168 [TBL] [Abstract][Full Text] [Related]
16. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease]. Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098 [TBL] [Abstract][Full Text] [Related]
17. [Bronchoalveolar lavage in diffuse interstitial lung diseases]. Music E; Mermolja M; Debeljak A; Sorli J Plucne Bolesti; 1984; 36(1-2):69-72. PubMed ID: 6514849 [No Abstract] [Full Text] [Related]
18. Transbronchial lung biopsy in pulmonary sarcoidosis. Is it an evaluable method in detection of disease activity? Poletti V; Patelli M; Spiga L; Ferracini R; Manetto V Chest; 1986 Mar; 89(3):361-5. PubMed ID: 3485033 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Tazi A; Nioche S; Chastre J; Smiéjan JM; Hance AJ Am J Respir Cell Mol Biol; 1991 Feb; 4(2):140-7. PubMed ID: 1703767 [TBL] [Abstract][Full Text] [Related]
20. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Abbott GF; Rosado-de-Christenson ML; Franks TJ; Frazier AA; Galvin JR Radiographics; 2004; 24(3):821-41. PubMed ID: 15143231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]